Provided By GlobeNewswire
Last update: Mar 13, 2025
Discovery Analysis Demonstrates Transformative Sensitivity of 95% with Specificity of 98% for the Detection of Pancreatic Cancer in Blood Samples
MAINZ BIOMED NV
NASDAQ:MYNZ (4/25/2025, 6:30:11 PM)
3.53
+0.33 (+10.31%)
Find more stocks in the Stock Screener